tiprankstipranks
Avenue Therapeutics Inc (ATXI)
NASDAQ:ATXI
US Market

Avenue Therapeutics (ATXI) Technical Analysis

Compare
321 Followers

Technical Sentiment

Overall Consensus
Sell
3Bullish
6Neutral
12Bearish
Technical Analysis Consensus
Buy
2Bullish
6Neutral
1Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Avenue Therapeutics Inc’s (ATXI) Moving Averages Convergence Divergence (MACD) indicator is -0.09, suggesting Avenue Therapeutics Inc is a Sell.
Avenue Therapeutics Inc’s (ATXI) 20-Day exponential moving average is 1.43, while Avenue Therapeutics Inc’s (ATXI) share price is $1.36, making it a Sell.
Avenue Therapeutics Inc’s (ATXI) 50-Day exponential moving average is 1.63, while Avenue Therapeutics Inc’s (ATXI) share price is $1.36, making it a Sell.

Avenue Therapeutics (ATXI) Pivot Points

Feb 22, 2025, 03:15 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.33
1.35
1.38
1.40
1.43
1.45
1.48
Fibonacci
1.35
1.37
1.38
1.40
1.42
1.43
1.45
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Avenue Therapeutics (ATXI) Moving Averages

Feb 22, 2025, 03:15 PM
Period
Simple
Exponential
MA5
1.39Sell
1.38Sell
MA10
1.34Buy
1.37Sell
MA20
1.38Sell
1.43Sell
MA50
1.66Sell
1.63Sell
MA100
1.89Sell
2.08Sell
MA200
2.54Sell
3.51Sell
Avenue Therapeutics Inc’s (ATXI) 10-Day exponential moving average is 1.37, while Avenue Therapeutics Inc’s (ATXI) share price is $1.36, making it a Sell.
Avenue Therapeutics Inc’s (ATXI) 100-Day exponential moving average is 2.08, while Avenue Therapeutics Inc’s (ATXI) share price is $1.36, making it a Sell.
Avenue Therapeutics Inc’s (ATXI) stock price is $1.36 and Avenue Therapeutics Inc’s (ATXI) 50-day simple moving average is 1.66, creating a Sell signal.
Avenue Therapeutics Inc’s (ATXI) stock price is $1.36 and Avenue Therapeutics Inc’s (ATXI) 100-day simple moving average is 1.89, creating a Sell signal.
Avenue Therapeutics Inc’s (ATXI) stock price is $1.36 and Avenue Therapeutics Inc’s (ATXI) 200-day simple moving average is 2.54, creating a Sell signal.

Avenue Therapeutics (ATXI) Technical Indicators

Feb 22, 2025, 03:15 PM
Name
Value
Implied Action
RSI (14)
41.79
Neutral
STOCH (9,6)
78.79
Neutral
STOCHRSI (14)
78.79
Neutral
MACD (12,26)
-0.09
Sell
ADX (14)
21.71
Neutral
Williams %R
-36.36
Buy
CCI (14)
7.61
Neutral
ATR (14)
0.13
-
Ultimate Oscillator
47.61
Neutral
ROC
0.00
Buy
Avenue Therapeutics Inc’s (ATXI) Relative Strength Index (RSI) is 41.79, creating a Neutral signal.
Avenue Therapeutics Inc’s (ATXI) Trend Strength Indicator (ADX) is 21.71, creating a Neutral signal.
Avenue Therapeutics Inc’s (ATXI) Commodity Channel Index (CCI) is 7.61, creating a Neutral signal.

FAQ

Is ATXI a Buy, Hold, or Sell?
Based on ATXI’s technical indicators, ATXI is a Sell.
    What is ATXI’s RSI (14)?
    ATXI’s RSI (14) is 41.79, which suggests ATXI is a Neutral.
      What is ATXI’s MACD?
      ATXI’s MACD is -0.09, which suggests ATXI is a Sell.
        What is ATXI’s 5-day moving average?
        ATXI’s 5-day moving average is 1.39, which suggests ATXI is a Sell.
          What is ATXI’s 20-day moving average?
          ATXI 20-day moving average is 1.38, which suggests ATXI is a Sell.
            What is ATXI’s 50-day moving average?
            ATXI’s 50-day moving average is 1.66, which suggests ATXI is a Sell.
              What is ATXI’s 200-day moving average?
              ATXI’s 200-day moving average is 2.54, which suggests ATXI is a Sell.
                What is ATXI’s Williams % R (14)?
                ATXI’s Williams % R (14) is -36.36, which suggests ATXI is a Buy.
                  What is ATXI’s CCI (14)?
                  ATXI’s CCI (14) is 7.61, which suggests ATXI is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis